Evidence map›Paper›PMID 34073013›Full record

ArticleInternational journal of molecular sciences2021

Precious-Metal-Decorated Chromium(IV) Oxide Nanowires as Efficient Catalysts for 2,4-Toluenediamine Synthesis.

Viktória Hajdu, Alexandra Jakab-Nácsa, Gábor Muránszky, István Kocserha, Béla Fiser, Tibor Ferenczi, Miklós Nagy, Béla Viskolcz, László Vanyorek

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Viktória HajduInstitute of Chemistry, University of Miskolc, Miskolc-Egyetemváros, 3515 Miskolc, Hungary.
Alexandra Jakab-NácsaInstitute of Chemistry, University of Miskolc, Miskolc-Egyetemváros, 3515 Miskolc, Hungary.
Gábor MuránszkyInstitute of Chemistry, University of Miskolc, Miskolc-Egyetemváros, 3515 Miskolc, Hungary.
István KocserhaInstitute of Ceramics and Polymer Engineering, University of Miskolc, Miskolc-Egyetemváros, 3515 Miskolc, Hungary.
Béla FiserInstitute of Chemistry, University of Miskolc, Miskolc-Egyetemváros, 3515 Miskolc, Hungary.ORCID 0000-0003-0603-4626
Tibor FerencziInstitute of Metallurgy, University of Miskolc, Miskolc-Egyetemváros, 3515 Miskolc, Hungary.
Miklós NagyInstitute of Chemistry, University of Miskolc, Miskolc-Egyetemváros, 3515 Miskolc, Hungary.ORCID 0000-0002-3484-2244
Béla ViskolczInstitute of Chemistry, University of Miskolc, Miskolc-Egyetemváros, 3515 Miskolc, Hungary.ORCID 0000-0002-0777-9569
László VanyorekInstitute of Chemistry, University of Miskolc, Miskolc-Egyetemváros, 3515 Miskolc, Hungary.
University of Miskolc · HU

Funding

European Regional Development Fund GINOP-2.3.4-15-2016-00004
6 · The paper itself

Abstract

The catalytic hydrogenation of 2,4-dinitrotoluene (DNT) to 2,4-toluenediamine (TDA) is a key step in the production of polyurethanes; therefore, the development of efficient hydrogenation catalysts for industrial use is of paramount importance. In the present study, chromium(IV) oxide nanowires were decorated by palladium and platinum nanoparticles in a one-step, simple, and fast preparation method to yield highly efficient hydrogenation catalysts for immediate use. The nanoparticles were deposited onto the surface of CrO

Indexed as

CatalysisChromium CompoundsMetal NanoparticlesNanowiresPalladiumPlatinumChromium Compoundschromium dioxidePalladiumPlatinum2,4-toluenediamineactivation energyhydrogenationmagnetic catalystnanowire

Identifiers

PMID34073013
PMCPMC8198398
OpenAlexW3164531062

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.